Viral Gastroenteritis Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Viral Gastroenteritis Market?
The surging instances of gastrointestinal disorders are anticipated to fuel the expansion of the viral gastroenteritis market in the future. Gastrointestinal (GI) disorders pertain to diseases that affect any part of the gastrointestinal tract. Drugs and diagnostic treatments for viral gastroenteritis ease the suffering of patients by providing the right medication. For instance, the IBD Clinical and Research Centre in Canada, in a report called Impact of IBD Report 2023 released in September 2023, showed a prevalance of 825 for every 100,000 persons, signifying that over 320,000 Canadians have inflammatory bowel disease (IBD). Since its prevalence rate is predicted to grow by 2.44% every year, by 2035, it’s projected that 1.1% of the population or 470,000 Canadians will be affected by IBD. Consequently, the rising instances of gastrointestinal disorders are leading the growth of the viral gastroenteritis market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp
#How Does the ProjectedViral Gastroenteritis Market Growth Compare Over the Forecast Period?
The market size for viral gastroenteritis has been experiencing a consistent growth in the past few years. The market is projected to expand from $6.75 billion in 2024 to $7.08 billion in 2025, with a compound annual growth rate (CAGR) of 5.0%. The historic growth of this market can be linked to factors such as the increasing occurrence of viral infections, worldwide hygiene habits, progress in diagnostic practices, international travel and tourism, as well as climate and environmental elements.
Expectations for the viral gastroenteritis market predict a significant expansion in the coming years. The market is speculated to attain a value of $8.73 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.4%. The augmentation during the projection period is attributed to preparedness in global health scenarios, effects of climate change, employment of a holistic health approach, systems for epidemiological surveillance, education, and public familiarity with the matter. Key tendencies during the forecast phase include progressing vaccine research, enhancement in diagnostics, use of telemedicine for diagnosis, cooperative research endeavours, personalised methodologies towards medicine, and the advent of digital healthcare solutions.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12127
What Are the Key Market Innovations in theViral Gastroenteritis Market Over the Coming Years?
The prominent trend making waves in the viral gastroenteritis market is product innovation. To secure their place in the market, numerous leading companies are emphasizing on the creation of novel products. One prime example is GlaxoSmithKline PLC, a biopharmaceutical entity from UK. In November 2022, they earned the approval from the US Food and Drug Administration (FDA) for their oral-dosing applicator-only presentation (a liquid formulation) of ROTARIX, which aims to counteract rotavirus gastroenteritis in infants. This new delivery system not only enhances convenience for healthcare practitioners by doing away with the necessity to reconstitute the vaccine dose at usage point, but also has strong backing from international clinical trial evidence showcasing its safety, tolerance before the lyophilized formulation, and comparable immunogenicity.
Who Are the Top Companies Driving Innovation and Growth in theViral Gastroenteritis Market?
Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report
Which Key Market Segments Comprise the Viral Gastroenteritis Market and Drive Its Revenue Growth?
The viral gastroenteritis market covered in this report is segmented –
1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins
2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate
3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners
4) By Antimotility Agents: Loperamide, Diphenoxylate
5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12127&type=smp
Which Regions Are Emerging as Leaders in the Viral Gastroenteritis Market?
North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Viral Gastroenteritis Maret 2025, By The Business Research Company:
Forklift Truck Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/forklift-truck-global-market-report
Smart And Mobile Supply Chain Solutions Global Market Report 2024
Warehouse Execution System Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/warehouse-execution-system-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
